Physician profile
Andrew D Yoder
NPI 1144608415
$1,320.97
in general payments reported to CMS, 2019-2025
12 companies · $160 in 2025
The $160 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $19.40 · 2022: $150 · 2023: $707 · 2024: $163 · 2025: $160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $745 · Travel and Lodging: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $744.65 |
| Travel and Lodging | $284.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $630.42 | 2023-2025 | Air Optix, Dailies Aqua Comfort Plus, Dailies Total1 Multifocal |
| Oyster Point Pharma, INC. | $173.88 | 2022-2023 | Tyrvaya |
| Genentech USA, INC. | $122.16 | 2019 | |
| Bausch & Lomb Americas INC. | $119.71 | 2023-2025 | Xiidra, Miebo, Vyzulta |
| Abbvie INC. | $70.41 | 2023-2024 | Vuity, Lumigan, Alphagan P |
| Tarsus Pharmaceuticals, INC. | $51.34 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $33.30 | 2024-2025 | |
| Coopervision INC. | $29.28 | 2023 | Myday Contact Lens |
| Astellas Pharma US INC | $28.00 | 2024 | Izervay |
| Novartis Pharmaceuticals Corporation | $21.79 | 2023 | |
| Dompe US, INC. | $21.28 | 2025 | Oxervate |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Yoder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.